​

Ambu A/S

CPSE:AMBU B Stock Report

Market Cap: DKK 25.6b

Ambu (AMBU B) Stock Overview

A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details

AMBU B fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 30.2% below our estimate of its fair value

Earnings are forecast to grow 25.25% per year

Earnings have grown 5.4% per year over the past 5 years

Analysts in good agreement that stock price will rise by 35.8%

Risk Analysis

Large one-off items impacting financial results


AMBU B Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

AMBU B logo
Ambu
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts

Global Competition And Regulatory Hurdles Will Depress Endoscopy Demand

Key Takeaways Sustainability concerns and regulatory pressure threaten demand for single-use devices, undermining Ambu's growth and market position in key regions. Rising costs, tougher competition, and harsher regulations are squeezing margins and hindering both expansion and earnings potential.
View narrative
DKK 94.54
FV
1.8% overvalued intrinsic discount
10.67%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
10 days ago author updated this narrative
AMBU B logo
Ambu
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

New SureSight Launch Will Strengthen Leadership In Airway Visualization

Key Takeaways Strong growth in Endoscopy Solutions and new product launches suggest future revenue boosts in key medical sectors and airway visualization. Operational improvements and strategic focus on innovation indicate enhanced net margins and sustained earnings growth prospects.
View narrative
DKK 147.11
FV
34.6% undervalued intrinsic discount
12.18%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
4 days ago author updated this narrative
AMBU B logo
Ambu
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts

Aging Population Will Boost Global Single-use Endoscopy Adoption

Key Takeaways Rapid hospital conversion to single-use solutions, infection control trends, and minimal churn could accelerate revenue and margin growth beyond current expectations. Early adoption of sustainable, reusable endoscopy, strong cash reserves, and digital innovation position Ambu for premium pricing, market share gains, and strategic acquisitions.
View narrative
DKK 147.00
FV
34.5% undervalued intrinsic discount
12.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
10 days ago author updated this narrative
View Ambu Community

Ambu A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ambu
Historical stock prices
Current Share PriceDKK 96.25
52 Week HighDKK 154.60
52 Week LowDKK 90.70
Beta1.25
1 Month Change-0.82%
3 Month Change-18.78%
1 Year Change-30.71%
3 Year Change30.35%
5 Year Change-59.34%
Change since IPO5,520.44%

Recent News & Updates

Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

Recent updates

Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts

Feb 02
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%

Jan 12
Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%

Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?

Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
author-image

Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth

Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.

Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02
A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31
Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19
Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12
Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07
Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Jan 20
We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Dec 08
Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Sep 23
Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 08
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Aug 21
We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Shareholder Returns

AMBU BDK Medical EquipmentDK Market
7D-3.3%-1.1%-0.8%
1Y-30.7%-25.5%-36.0%

Return vs Industry: AMBU B underperformed the Danish Medical Equipment industry which returned -23.8% over the past year.

Return vs Market: AMBU B exceeded the Danish Market which returned -34% over the past year.

Price Volatility

Is AMBU B's price volatile compared to industry and market?
AMBU B volatility
AMBU B Average Weekly Movement5.5%
Medical Equipment Industry Average Movement5.5%
Market Average Movement4.9%
10% most volatile stocks in DK Market8.4%
10% least volatile stocks in DK Market2.6%

Stable Share Price: AMBU B has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: AMBU B's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19375,000Britt Jensenwww.ambu.com

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Ambu A/S Fundamentals Summary

How do Ambu's earnings and revenue compare to its market cap?
AMBU B fundamental statistics
Market capDKK 25.64b
Earnings (TTM)DKK 370.00m
Revenue (TTM)DKK 5.83b
69.3x
P/E Ratio
4.4x
P/S Ratio

Is AMBU B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBU B income statement (TTM)
RevenueDKK 5.83b
Cost of RevenueDKK 2.32b
Gross ProfitDKK 3.52b
Other ExpensesDKK 3.15b
EarningsDKK 370.00m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 22, 2025

Earnings per share (EPS)1.39
Gross Margin60.27%
Net Profit Margin6.34%
Debt/Equity Ratio0%

How did AMBU B perform over the long term?

See historical performance and comparison

Dividends

0.4%
Current Dividend Yield
27%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/13 10:07
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ambu A/S is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Michael HealyBerenberg
Alexander BerglundBofA Global Research